Stock analysis searches answered, part 29 of 43

American eagle outfitters trump x truth social

For “American eagle outfitters trump x truth social”, the matching SEC registrant is AMERICAN EAGLE OUTFITTERS INC, which trades as AEO and files under Central Index Key 919012. EDGAR puts it in the “Retail-Family Clothing Stores” industry code with DE as its state or country of incorporation; its earlier registered name was AMERICAN EAGLE OUTFITTERS INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-07 (this view begins at filings dated on or before 2026-08-05), across 1002 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-30 by AMERICAN EAGLE OUTFITTERS INC (CIK 919012) (passage 2, continuing from the earlier excerpt) — source document:

We operate stores in the U.S., Canada, and Mexico. We also have license agreements with third parties to operate American Eagle and Aerie stores and online marketplace businesses throughout Asia (including India), Europe, Latin America, and the Middle East. We also operate Todd Snyder New York ("Todd Snyder"), a premium menswear brand; and Unsubscribed, which focuses on consciously made, slow fashion. Through the end of Fiscal 2025, we operated Quiet Platforms, which primarily served as AEO's regionalized fulfillment center network while also utilizing excess space to service appropriate third-party customers. In Fiscal 2025, as part of our continued supply chain network optimization project, we made the decision to close the Quiet Platforms business and discontinue services for all third-party customers.

Financial trend for AMERICAN EAGLE OUTFITTERS INC from quarterly and annual reports (three-month periods), periods 2025-11-01 to 2026-08-01: revenue went from $1.36 billion (2025-11-01) to $1.38 billion (2026-08-01), a change of +1.3%; net income (loss) went from $91.34 million (2025-11-01) to $134.08 million (2026-08-01), a change of +46.8%; total assets went from $4.19 billion (2025-11-01) to $4.28 billion (2026-08-01), a change of +2.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 919012, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 3 periods shown, dashes mark figures AMERICAN EAGLE OUTFITTERS INC did not tag for that period.

Current reports. Of the 69 8-K or 6-K reports in AMERICAN EAGLE OUTFITTERS INC’s recent EDGAR index, the 4 listed here run from 2025-12-02 to 2026-05-28, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 919012 is on the EDGAR company page; the latest 10-K there is dated 2026-03-30 and the oldest filing in the recent index dates from 2019-07-30. One example from this record is the 4 filed 2026-10-05 (document). Insider trades for AMERICAN EAGLE OUTFITTERS INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Apnimed

For “Apnimed”, the matching SEC registrant is Apnimed, Inc., which trades as APMD and files under Central Index Key 1745648. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a S-8 filed 2026-09-08 (this view begins at filings dated on or before 2026-08-03), across 54 filings on record. This is reference material, not trading advice.

Financial trend for Apnimed, Inc. from quarterly and annual reports (three-month periods), periods 2025-06-30 to 2026-06-30: revenue went from $17.11 million (2025-06-30) to $12.08 million (2026-06-30), a change of -29.4%; net income (loss) went from -$69.47 million (2025-06-30) to $125.94 million (2026-06-30), a change of +281.3%; total assets was tagged only for 2026-06-30 at $195.46 million. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1745648, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Apnimed, Inc. did not tag for that period.

Apnimed, Inc. has 54 filings in its recent EDGAR index, including 0 annual reports and 1 quarterly reports; its newest filing is a S-8 from 2026-09-08.

Other filings. Across its 54 recent EDGAR filings, Apnimed, Inc. most often filed 3 (11), 4 (10), D (9), D/A (6). A selection from 2026-08-03 to 2026-08-05:

The full record for CIK 1745648 is on the EDGAR company page and the oldest filing in the recent index dates from 2018-07-06. One example from this record is the SCHEDULE 13G filed 2026-08-06 (document). Insider trades for Apnimed, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Ardent health ardt news october 2026

For “Ardent health ardt news october 2026”, the matching SEC registrant is Ardent Health, Inc., which trades as ARDT and files under Central Index Key 1756655. EDGAR puts it in the “Services-General Medical & Surgical Hospitals, NEC” industry code with DE as its state or country of incorporation; its earlier registered name was Ardent Health Partners, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-23, across 174 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-16 by Ardent Health, Inc. (CIK 1756655) — source document:

Ardent Health, Inc. was initially formed in Delaware in 2015 as Ardent Health Partners, LLC. On July 17, 2024, Ardent Health Partners, LLC converted from a Delaware limited liability company into a Delaware corporation in connection with its initial public offering and changed its name to Ardent Health Partners, Inc. On June 3, 2025, Ardent Health Partners, Inc. changed its name to Ardent Health, Inc. Ardent Health, Inc. is a holding company that has affiliates that operate acute care hospitals and other healthcare facilities and employ physicians. The terms "Ardent," the "Company," "we," "our" and "us," as used in this Annual Report on Form 10-K ("Annual Report"), refer to Ardent Health, Inc. and its affiliates and, on or prior to July 16, 2024, Ardent Health Partners, LLC and its affiliates, unless stated otherwise or indicated by context.

Financial trend for Ardent Health, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $5.13 billion (2022-12-31) to $6.32 billion (2025-12-31), a change of +23.3%; net income (loss) went from $188.91 million (2022-12-31) to $135.81 million (2025-12-31), a change of -28.1%; total assets went from $4.73 billion (2023-12-31) to $5.29 billion (2025-12-31), a change of +11.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1756655, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Ardent Health, Inc. did not tag for that period.

For the latest news, the fastest official source is the filing feed: Ardent Health, Inc. (CIK 1756655) filed 22 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-23, and its overall latest filing is a 8-K dated 2026-10-23. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 22 8-K or 6-K reports in Ardent Health, Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-30 to 2026-10-23, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1756655 is on the EDGAR company page; the latest 10-K there is dated 2026-03-16 and the oldest filing in the recent index dates from 2018-10-26. Insider trades for Ardent Health, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Armata pharmaceuticals

For “Armata pharmaceuticals”, the matching SEC registrant is Armata Pharmaceuticals, Inc., which trades as ARMP and files under Central Index Key 921114. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with WA as its state or country of incorporation; its earlier registered name was AmpliPhi Biosciences Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-09-23, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-25 by Armata Pharmaceuticals, Inc. (CIK 921114) — source document:

We are a leading developer of clinical-stage phage therapeutics of high purity and potency, and believe we are uniquely positioned to address the growing worldwide threat of antibiotic-resistant bacterial infections. ​ We are combining our proprietary approach and expertise in identifying, characterizing and developing both naturally occurring and engineered bacteriophages with our proprietary phage-specific host-engineered cGMP manufacturing capabilities to advance a clinical pipeline of high-quality bacteriophage product candidates. We believe that we are uniquely advancing two distinct clinical candidates, referred to as AP-PA02 and AP-SA02, targeting two different bacterial pathogens with the potential to treat chronic pulmonary disease complicated by bacterial infection as well as acute systemic bacterial infection. To date, we have completed three critical Phase 2 randomized, double-blind, placebo controlled clinical trials.

Financial trend for Armata Pharmaceuticals, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$36.92 million (2022-12-31) to -$173.80 million (2025-12-31), a change of -370.8%; total assets went from $95.83 million (2022-12-31) to $76.88 million (2025-12-31), a change of -19.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 921114, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures Armata Pharmaceuticals, Inc. did not tag for that period.

Armata Pharmaceuticals, Inc. has 1000 filings in its recent EDGAR index, including 19 annual reports and 56 quarterly reports; its newest filing is a 8-K from 2026-09-23.

Current reports. Of the 282 8-K or 6-K reports in Armata Pharmaceuticals, Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-20 to 2026-09-23, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 921114 is on the EDGAR company page; the latest 10-K there is dated 2026-03-25 and the oldest filing in the recent index dates from 2004-01-27. Insider trades for Armata Pharmaceuticals, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Atlx stock

For “Atlx stock”, the matching SEC registrant is Atlas Lithium Corp, which trades as ATLX and files under Central Index Key 1540684. EDGAR puts it in the “Mining & Quarrying of Nonmetallic Minerals (No Fuels)” industry code with NV as its state or country of incorporation; its earlier registered name was Brazil Minerals, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-01, across 626 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-04 by Atlas Lithium Corp (CIK 1540684) — source document:

Atlas Lithium Corporation (“Atlas Lithium”, the “Company”, “we”, “us”, or “our” refer to Atlas Lithium Corporation and its consolidated subsidiaries) is a mineral exploration and development company with lithium projects and multiple lithium exploration properties. In addition, we own exploration properties in other battery minerals, including nickel, copper, rare earths, graphite, and titanium. Our current focus is the continued advancement of our hard-rock lithium project in Minas Gerais, Brazil toward active mining. The project is located within a well-known lithium-bearing pegmatitic district designated by the state government as “Lithium Valley.” We intend to mine and then process our lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.

Financial trend for Atlas Lithium Corp from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $6,765 (2022-12-31) to $92,491 (2025-12-31), a change of +1267.2%; net income (loss) went from -$4.93 million (2022-12-31) to -$28.11 million (2025-12-31), a change of -470.0%; total assets went from $5.07 million (2022-12-31) to $87.70 million (2025-12-31), a change of +1630.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1540684, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Atlas Lithium Corp did not tag for that period.

Atlas Lithium Corp has 626 filings in its recent EDGAR index, including 14 annual reports and 44 quarterly reports; its newest filing is a 4 from 2026-10-01.

Current reports. Of the 83 8-K or 6-K reports in Atlas Lithium Corp’s recent EDGAR index, the 4 listed here run from 2026-04-07 to 2026-06-29, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1540684 is on the EDGAR company page; the latest 10-K/A there is dated 2026-08-14 and the oldest filing in the recent index dates from 2012-04-06. Insider trades for Atlas Lithium Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Axiom apg mexico

What this search refers to. “Axiom APG Mexico” names a Mexican business; Mexican private companies are recorded in the Registro Público de Comercio, and only BMV-listed issuers publish market disclosures. Official source: www.bmv.com.mx.

No SEC filer could be matched to “Axiom apg mexico” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Axiom apg mexico”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “axiom” (search terms considered: axiom, apg, mexico).

The wording suggests a business based in Mexico. Companies there file with the Mexican Stock Exchange (BMV) and the CNBV rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “axiom” is therefore the Mexico regulator or exchange site, where annual reports and stock-exchange announcements are published.

EDGAR’s company index has 132 entities whose registered name contains the word “axiom”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “axiom” 132, “apg” 13, “mexico” 352. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: if “axiom” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Bausch + lomb blco latest news october 2026

For “Bausch + lomb blco latest news october 2026”, the matching SEC registrant is Bausch & Lomb Corp, which trades as BLCO and files under Central Index Key 1860742. EDGAR puts it in the “Ophthalmic Goods” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-13, across 362 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-18 by Bausch & Lomb Corp (CIK 1860742) — source document:

Bausch + Lomb Corporation (and its subsidiaries) (“Bausch + Lomb,” “we,” “us,” “our” or the “Company”) is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our mission is simple, yet powerful: helping you see better, to live better. Founded in 1853, Bausch + Lomb has a significant global research, development, manufacturing and commercial footprint of approximately 13,000 employees and a presence in approximately 100 countries. As a fully integrated eye health business, Bausch + Lomb has a comprehensive portfolio of approximately 400 products, which includes an established line of contact lenses, intraocular lenses ("IOLs") and other medical devices, surgical systems and devices, vitamin and mineral supplements, lens care products, prescription eye-medications and other consumer products that positions us to compete in all areas of the eye health market.

Financial trend for Bausch & Lomb Corp from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $3.77 billion (2022-12-31) to $5.10 billion (2025-12-31), a change of +35.4%; net income (loss) went from $6.00 million (2022-12-31) to -$360.00 million (2025-12-31), a change of -6100.0%; total assets went from $11.14 billion (2022-12-31) to $14.02 billion (2025-12-31), a change of +25.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1860742, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Bausch & Lomb Corp did not tag for that period.

For the latest news, the fastest official source is the filing feed: Bausch & Lomb Corp (CIK 1860742) filed 51 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-13, and its overall latest filing is a 8-K dated 2026-10-13. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 51 8-K or 6-K reports in Bausch & Lomb Corp’s recent EDGAR index, the 4 listed here run from 2026-05-20 to 2026-10-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1860742 is on the EDGAR company page; the latest 10-K there is dated 2026-02-18 and the oldest filing in the recent index dates from 2021-05-27. Insider trades for Bausch & Lomb Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Bbdo india private limited mobile apps

“Bbdo india private limited” is searched here together with “mobile apps”, so the question is which apps the business publishes, not its SEC record. App listings show the developer’s legal name; the authoritative places to check are Google Play’s developer search and Apple’s App Store, where an app published by Bbdo india private limited would show that exact name under “Developer” or “Seller”.

No SEC filer could be matched to “Bbdo india private limited mobile apps” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Bbdo india private limited”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “bbdo” (search terms considered: bbdo, india, private).

Even the shorter phrase “Bbdo india private” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (bbdo, india, private) point to a business outside the SEC system or one known by another legal name.

The wording suggests a business based in India. Companies there file with NSE/BSE and the Securities and Exchange Board of India (SEBI) rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “bbdo” is therefore the India regulator or exchange site, where annual reports and stock-exchange announcements are published.

EDGAR’s company index has 0 entities whose registered name contains the word “bbdo”, so the business is most likely not registered with the SEC under that name.

Word by word, the number of EDGAR registrant names containing each term of this search is: “bbdo” 0, “india” 472, “private” 491. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “india”: 3 ALPHA INDIA MULTI MANAGER EQUITY FUND SPV LP (CIK 2029439), 360 ONE INDIA EQUITY FUND (CIK 1991415), 360 ONE INDIA SELECT FUND 2 (CIK 2092687); containing “private”: 10 EAST PRIVATE MARKETS FUND L.P. (CIK 2140603), 1031CF REAL ESTATE PRIVATE CREDIT FUND, LLC (CIK 2124729), 10TALENTS PRIVATE FUND I, L.P. (CIK 1700300). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

Updated Oct 25, 2026 ET

Biocardia

For “Biocardia”, the matching SEC registrant is BioCardia, Inc., which trades as BCDA and files under Central Index Key 925741. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with DE as its state or country of incorporation; its earlier registered name was Tiger X Medical, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-20, across 1002 filings on record. This is reference material, not trading advice.

Financial trend for BioCardia, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$11.91 million (2022-12-31) to -$8.23 million (2025-12-31), a change of +30.9%; total assets went from $9.79 million (2022-12-31) to $3.41 million (2025-12-31), a change of -65.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 925741, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures BioCardia, Inc. did not tag for that period.

BioCardia, Inc. has 1002 filings in its recent EDGAR index, including 19 annual reports and 57 quarterly reports; its newest filing is a 4 from 2026-10-20.

Current reports. Of the 234 8-K or 6-K reports in BioCardia, Inc.’s recent EDGAR index, the 4 listed here run from 2026-09-23 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 1002 recent EDGAR filings, BioCardia, Inc. most often filed 4 (366), 8-K (234), 10-Q (57), 3 (36). A selection from 2026-08-18 to 2026-10-20:

The full record for CIK 925741 is on the EDGAR company page; the latest 10-K there is dated 2026-03-24 and the oldest filing in the recent index dates from 2007-09-27. Insider trades for BioCardia, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Blaize bzai press release latest

For “Blaize bzai press release latest”, the matching SEC registrant is Blaize Holdings, Inc., which trades as BZAI, BZAIW and files under Central Index Key 1871638. EDGAR puts it in the “Semiconductors & Related Devices” industry code with DE as its state or country of incorporation; its earlier registered name was Blaize Holdings, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-22, across 317 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-24 by Blaize Holdings, Inc. (CIK 1871638) — source document:

Blaize Holdings, Inc. (“Blaize,” the “Company,” “we,” “us,” and “our”) develops purpose-built AI-enabled computing solutions comprised of both our proprietary hardware and software, and complementary third-party hardware solutions, as further described below. Our computing solutions are designed for efficient processing of AI inference workloads across edge and data center environments. Our architecture supports AI workloads where latency, power efficiency, and cost efficiency are important considerations. Our systems can process data locally at the edge or within data center infrastructure, depending on deployment requirements. Local processing can reduce bandwidth usage and support latency-sensitive applications requiring real-time decision making. In addition to our internally developed products, we also deliver third-party hardware solutions that complement and enhance our core offerings.

Financial trend for Blaize Holdings, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $1.55 million (2024-12-31) to $38.63 million (2025-12-31), a change of +2386.0%; net income (loss) went from $1.67 million (2022-12-31) to -$206.90 million (2025-12-31), a change of -12462.8%; total assets went from $296.01 million (2022-12-31) to $102.21 million (2025-12-31), a change of -65.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1871638, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Blaize Holdings, Inc. did not tag for that period.

For the latest news, the fastest official source is the filing feed: Blaize Holdings, Inc. (CIK 1871638) filed 55 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-22, and its overall latest filing is a 8-K dated 2026-10-22. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 55 8-K or 6-K reports in Blaize Holdings, Inc.’s recent EDGAR index, the 4 listed here run from 2026-09-30 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1871638 is on the EDGAR company page; the latest 10-K/A there is dated 2026-04-30 and the oldest filing in the recent index dates from 2021-08-19. Insider trades for Blaize Holdings, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Blaize holdings bzai news october 2026 earnings product infrastructure

For “Blaize holdings bzai news october 2026 earnings product infrastructure”, the matching SEC registrant is Blaize Holdings, Inc., which trades as BZAI, BZAIW and files under Central Index Key 1871638. EDGAR puts it in the “Semiconductors & Related Devices” industry code with DE as its state or country of incorporation; its earlier registered name was Blaize Holdings, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-22 (this view begins at filings dated on or before 2026-09-30), across 317 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-24 by Blaize Holdings, Inc. (CIK 1871638) (passage 2, continuing from the earlier excerpt) — source document:

By integrating certain third-party hardware components, we believe that we are able to provide customers with comprehensive and flexible computing solutions tailored to their specific needs. These third-party hardware solutions typically are substantially comprised of servers, which are selected to ensure optimal compatibility and performance with our products and our AI-enabled platforms. We are a Delaware corporation, incorporated in 2010, headquartered in El Dorado Hills, California. Merger and Reverse Recapitalization On January 13, 2025, BurTech completed the Merger, pursuant to the Merger Agreement, whereby Merger Sub merged with and into Legacy Blaize, with Legacy Blaize being the surviving company and a wholly owned subsidiary of BurTech. In connection with the de-SPAC, we changed our name from “BurTech Acquisition Corporation” to “Blaize Holdings, Inc.,” and the Merger was accounted for as a reverse merger and recapitalization, with BurTech considered the acquired company, and Legacy Blaize considered the acquirer, for financial statement reporting purposes.

Financial trend for Blaize Holdings, Inc. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: revenue was tagged only for 2025-09-30 at $11.87 million; net income (loss) went from -$26.26 million (2025-09-30) to -$28.81 million (2026-06-30), a change of -9.7%; total assets went from $60.90 million (2025-09-30) to $79.51 million (2026-06-30), a change of +30.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1871638, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Blaize Holdings, Inc. did not tag for that period.

For reported results, Blaize Holdings, Inc.’s (CIK 1871638) latest 10-Q is dated 2026-08-13 and its latest annual report (10-K) 2026-03-24. Earnings releases appear as 8-K Item 2.02 filings; 10 are in the recent index, the newest on 2026-10-06.

Current reports. Of the 55 8-K or 6-K reports in Blaize Holdings, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-06 to 2026-08-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1871638 is on the EDGAR company page; the latest 10-K/A there is dated 2026-04-30 and the oldest filing in the recent index dates from 2021-08-19. One example from this record is the 424B3 filed 2026-10-06 (document). Insider trades for Blaize Holdings, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Bmrn

For “Bmrn”, the matching SEC registrant is BIOMARIN PHARMACEUTICAL INC, which trades as BMRN and files under Central Index Key 1048477. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-06, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-26 by BIOMARIN PHARMACEUTICAL INC (CIK 1048477) — source document:

BioMarin Pharmaceutical Inc. (BioMarin, we, us or our) is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Our San Rafael, California-based company, founded in 1997, has a proven track record of innovation, with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, we seek to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. Recent Developments In 2025, we achieved $3.2 billion in total revenues, including a significant contribution from our ongoing expansion of VOXZOGO, and we continued to grow our commercial business and advance our product candidate pipeline.

Financial trend for BIOMARIN PHARMACEUTICAL INC from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from $141.56 million (2022-12-31) to $348.90 million (2025-12-31), a change of +146.5%; total assets went from $6.38 billion (2022-12-31) to $7.59 billion (2025-12-31), a change of +19.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1048477, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures BIOMARIN PHARMACEUTICAL INC did not tag for that period.

BIOMARIN PHARMACEUTICAL INC has 1000 filings in its recent EDGAR index, including 10 annual reports and 29 quarterly reports; its newest filing is a 8-K from 2026-10-06.

Current reports. Of the 106 8-K or 6-K reports in BIOMARIN PHARMACEUTICAL INC’s recent EDGAR index, the 4 listed here run from 2026-09-14 to 2026-10-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1048477 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2017-01-19. Insider trades for BIOMARIN PHARMACEUTICAL INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Cane and able 0.11

What this search refers to. “Cane and Able 0.11” looks like a product or software version string, not a company; there is no issuer or filing behind it. Corporate-registry check: OpenCorporates search for “Cane and able 0.11”.

No SEC filer could be matched to “Cane and able 0.11” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Cane and able 0.11”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “cane” (search terms considered: cane, able).

Even the shorter phrase “Cane able 0.11” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (cane, able) point to a business outside the SEC system or one known by another legal name.

EDGAR’s company index has 30 entities whose registered name contains the word “cane”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “cane” 30, “able” 28. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “cane”: AI - CANE - SPV2, LLC (CIK 1829610), AMERICAN CANE DEC 2025 A SERIES OF CGF2021 LLC (CIK 2105241), BLUE CANE PARTNERS, LLC (CIK 1944845); containing “able”: ABLE BRANDS CO. (CIK 1849574), ABLE CAPITAL PARTNERS, LP (CIK 1615900), ABLE CHANNEL, INC. (CIK 1798949). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: if “cane” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Cisco integrated management controller 4.0(2c) cve

“Cisco integrated management controller 4.0(2c) cve” is a software-security lookup: CVE identifiers are assigned under the MITRE CVE program and scored in the U.S. National Vulnerability Database, and the vendor’s own advisories list the fixed releases. Search the NVD for this product and check the vendor security advisory page, because SEC filings only mention vulnerabilities in aggregate.

No SEC filer could be matched to “Cisco integrated management controller 4.0(2c) cve” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Cisco integrated management controller 4.0 2c”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “cisco” (search terms considered: cisco, integrated, management, controller).

Even the shorter phrase “Cisco integrated management” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (cisco, integrated, management, controller) point to a business outside the SEC system or one known by another legal name.

Word by word, the number of EDGAR registrant names containing each term of this search is: “cisco” 8, “integrated” 356, “management” 472, “controller” 2. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “cisco”: NOLAN CISCO PARTNERSHIP (CIK 1311603), PREMIER CISCO ACCESS FUND, L.P. (CIK 2070218); containing “integrated”: AQR EMERGING EQUITIES INTEGRATED ALPHA FUND, L.P. (CIK 1640643), AQR INTERNATIONAL EQUITY INTEGRATED ALPHA FUND, L.P. (CIK 1655909), AQUARIAN SOLUTIONS INTEGRATED LLC (CIK 1315333); containing “management”: 10K LAKES MANAGEMENT II, LLC (CIK 1873406), 10X CAPITAL MANAGEMENT, LLC (CIK 1457247), 10XYZ MANAGEMENT LLC (CIK 1861145); containing “controller”: CONNECTIVITY VENTURES FUND, LP - CONTROLLER SERIES (CIK 1915882), POLAR CONTROLLER, INC. (CIK 1748350). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

Updated Oct 25, 2026 ET

Cisco integrated management controller 4.0(4e) cve

“Cisco integrated management controller 4.0(4e) cve” is a software-security lookup: CVE identifiers are assigned under the MITRE CVE program and scored in the U.S. National Vulnerability Database, and the vendor’s own advisories list the fixed releases. Search the NVD for this product and check the vendor security advisory page, because SEC filings only mention vulnerabilities in aggregate.

No SEC filer could be matched to “Cisco integrated management controller 4.0(4e) cve” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Cisco integrated management controller 4.0 4e”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “cisco” (search terms considered: cisco, integrated, management, controller).

Sample EDGAR registrant names, term by term — containing “cisco”: CISCO BAY INC. (CIK 1705693), CISCO GLOBAL TECHNOLOGY INC (CIK 2068545), CISCO SYSTEMS (SWITZERLAND) INVESTMENTS LTD (CIK 1520564); containing “integrated”: ARIZONA INTEGRATED PHYSICIANS, INC. (CIK 1609792), ATLANTIC INTEGRATED HEALTH INC (CIK 1025990), ATO ATO INTEGRATED MEDIA INC. (CIK 1475048); containing “management”: 11 POINT CAPITAL MANAGEMENT LLC (CIK 1801039), 11.2 CAPITAL MANAGEMENT, LLC (CIK 2072160), 1107 PROPERTY MANAGEMENT, LLC (CIK 1772613); containing “controller”: CONNECTIVITY VENTURES FUND, LP - CONTROLLER SERIES (CIK 1915882), POLAR CONTROLLER, INC. (CIK 1748350). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

Release 4.0(4e) sits later in the 4.0 train than 4.0(2c), so some advisories that affect the earlier build are already fixed here. Cisco’s security advisories list affected and first-fixed releases per hardware platform, which is the authoritative way to decide whether this specific build needs an update.

Cjmb stock

For “Cjmb stock”, the matching SEC registrant is CALLAN JMB INC., which trades as CJMB and files under Central Index Key 2032545. EDGAR puts it in the “Services-Business Services, NEC” industry code with NV as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a POS AM filed 2026-10-20, across 97 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-31 by CALLAN JMB INC. (CIK 2032545) — source document:

We are headquartered at 244 Flightline Drive, Spring Branch, TX 78070. We also established an entity, Callan JMB Services (India) Private Limited is domiciled in Pune, Maharashtra, India and is 99.9% owned by Callan JMB and has no operations or activities as of December 31, 2025. The following diagram illustrates our corporate structure as of the date of this report: Our Strategy and Value Proposition Our strategy involves leveraging our core competitive strengths to develop and maintain ongoing relationships with a diversified group of customers while continuing to grow our service lines, ensuring that we can meet our customers’ changing needs. We strive to be recognized as the premier provider of logistics and fulfillment of a broad range of value-added services based upon the breadth of those services, quality, responsiveness, customer service, information technologies, safety, and cost effectiveness. 4 The principal elements of our business strategy are: Cross-Sell Our Solutions : The breadth of our service offerings allows us the opportunity to provide various services and products to meet our customers’ objectives.

Financial trend for CALLAN JMB INC. from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from $13.20 million (2023-12-31) to $5.72 million (2025-12-31), a change of -56.7%; net income (loss) went from $2.18 million (2023-12-31) to -$7.97 million (2025-12-31), a change of -465.2%; total assets went from $9.71 million (2023-12-31) to $5.78 million (2025-12-31), a change of -40.5%. Values are as filed and not adjusted for restatements, splits or currency.

CALLAN JMB INC. has 97 filings in its recent EDGAR index, including 2 annual reports and 5 quarterly reports; its newest filing is a POS AM from 2026-10-20.

Current reports. Of the 21 8-K or 6-K reports in CALLAN JMB INC.’s recent EDGAR index, the 4 listed here run from 2026-08-31 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2032545 is on the EDGAR company page; the latest 10-K there is dated 2026-03-31 and the oldest filing in the recent index dates from 2024-08-05. Insider trades for CALLAN JMB INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Clearway energy cwen news

For “Clearway energy cwen news”, the matching SEC registrant is Clearway Energy, Inc., which trades as CWEN and files under Central Index Key 1567683. EDGAR puts it in the “Electric Services” industry code with DE as its state or country of incorporation; its earlier registered name was NRG Yield, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-20 (this view begins at filings dated on or before 2026-09-28), across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-24 by Clearway Energy, Inc. (CIK 1567683) (passage 2, continuing from the earlier excerpt) — source document:

In 2025, 98% of the Company’s total generation was attributable to renewable energy and storage assets. Through this environmentally-sound, diversified and primarily contracted portfolio, the Company endeavors to provide its investors with stable and growing dividend income. The majority of the Company’s revenues are derived from long-term contractual arrangements for the output or capacity from these assets. The weighted average remaining contract duration of the Company’s Renewables & Storage segment offtake agreements was approximately 12 years as of December 31, 2025 based on CAFD. A complete listing of the Company’s interests in operating facilities as of December 31, 2025 can be found in Item 2 — Properties. The Company is the sole managing member of Clearway Energy LLC and operates and controls all of its business and affairs and consolidates the financial results of Clearway Energy LLC and its subsidiaries.

Financial trend for Clearway Energy, Inc. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: revenue went from $429.00 million (2025-09-30) to $481.00 million (2026-06-30), a change of +12.1%; net income (loss) went from $232.00 million (2025-09-30) to $122.00 million (2026-06-30), a change of -47.4%; total assets went from $16.07 billion (2025-09-30) to $16.77 billion (2026-06-30), a change of +4.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1567683, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Clearway Energy, Inc. did not tag for that period.

For the latest news, the fastest official source is the filing feed: Clearway Energy, Inc. (CIK 1567683) filed 139 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-20, and its overall latest filing is a 4 dated 2026-10-20. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 139 8-K or 6-K reports in Clearway Energy, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-15 to 2026-08-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1567683 is on the EDGAR company page; the latest 10-K there is dated 2026-02-24 and the oldest filing in the recent index dates from 2017-05-09. One example from this record is the 4 filed 2026-10-13 (document). Insider trades for Clearway Energy, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Commonwealth fusion systems arc virginia progress latest

Commonwealth Fusion Systems is a private company, so it files no 10-K or 10-Q and there is no XBRL financial data to show. The latest news on its ARC fusion plant planned for Chesterfield County, Virginia comes from the company’s own announcements and from public records kept by Virginia and county authorities, such as zoning and permitting decisions. Fusion facilities in the US are being regulated under the Nuclear Regulatory Commission’s byproduct-material framework rather than reactor licensing, so NRC and Virginia state rulemaking pages are further official sources for regulatory progress.

Listed companies that supply or invest in the company sometimes mention it in their own SEC filings, which is what the EDGAR full-text search results capture. Those mentions describe the filer’s relationship, not the plant’s schedule.

For the newest status of the planned ARC power plant, the company newsroom at cfs.energy is the primary source; regional utility and grid-interconnection filings in Virginia are a secondary check. Treat third-party timelines with caution: a privately held developer is under no obligation to publish schedule changes, and nothing on EDGAR would capture a delay.

Dao-yi chow

What this search refers to. Dao-Yi Chow is a fashion designer (co-founder of the label Public School); as a private individual he has no SEC filings unless he is an insider of a registrant. Corporate-registry check: OpenCorporates search for “Dao-yi chow”.

No SEC filer could be matched to “Dao-yi chow” with a single, clear Central Index Key: the phrase “Dao-yi chow” appears in 3 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “dao-yi” (search terms considered: dao-yi, chow).

In the 3 most relevant full-text hits returned for “Dao-yi chow”, filings range from 2016-07-25 to 2016-09-09. The filers whose documents mention it most often are G III APPAREL GROUP LTD /DE/ (GIII) (CIK 0000821002) (3 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 0 entities whose registered name contains the word “dao-yi”, so the business is most likely not registered with the SEC under that name.

Word by word, the number of EDGAR registrant names containing each term of this search is: “dao-yi” 0, “chow” 73. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “chow”: CHOW ALAN (CIK 1720541), CHOW ALAN C (CIK 1416695), CHOW ANDREW S (CIK 1273705). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: if “dao-yi” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Dental fet duo

What this search refers to. “Dental fet duo” is a dental product or device term, not an issuer; medical devices are listed in the FDA’s device databases, which are the official source for clearances. Official source: www.accessdata.fda.gov.

No SEC filer could be matched to “Dental fet duo” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Dental fet duo”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “dental” (search terms considered: dental, fet, duo).

EDGAR’s company index has 194+ entities whose registered name contains the word “dental”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “dental” 271, “fet” 3, “duo” 27. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “dental”: ACCELERATE DENTAL HOLDINGS, LLC (CIK 2007106), ACIERNO DENTAL, LLC (CIK 1550432), ADVANTAGE DENTAL IDAHO LLC (CIK 1528878); containing “fet”: FET HOLDINGS, LLC (CIK 1615187), FOCUS ENERGY TRUST & FET RESOURCES LTD/FI (CIK 1275529), TINICUM FET, LLC (CIK 1550985); containing “duo”: ADAIR DUO DEVELOPMENT GP (CIK 1703000), ANGELSDECK SPC DUO LLC (CIK 1889242), CINCINNATI DUO, LLC (CIK 1791084). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: if “dental” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Diamedica therapeutics

For “Diamedica therapeutics”, the matching SEC registrant is DiaMedica Therapeutics Inc., which trades as DMAC and files under Central Index Key 1401040. EDGAR puts it in the “Pharmaceutical Preparations” industry code with Canada (Federal Level) as its state or country of incorporation; its earlier registered name was DiaMedica Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-08-12, across 427 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-30 by DiaMedica Therapeutics Inc. (CIK 1401040) — source document:

We are a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from severe ischemic disease with two main clinical programs focused on preeclampsia (PE) / fetal growth restriction (FGR) and acute ischemic stroke (AIS). Our lead candidate DM199 (rinvecalinase alfa), is the first pharmaceutically active recombinant (synthetic) form of the human tissue kallikrein-1 (rhKLK1) protein to be clinically studied in patients and has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) for the treatment of AIS. Kallikrein-1 (KLK1), extracted from human urine, is an established therapeutic modality in Asia for the treatment of AIS, and KLK1 produced from pig pancreas, is an established therapeutic modality for the treatment of cardio renal disease, including hypertension, in Asia.

Financial trend for DiaMedica Therapeutics Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$13.68 million (2022-12-31) to -$32.77 million (2025-12-31), a change of -139.6%; total assets went from $34.40 million (2022-12-31) to $61.37 million (2025-12-31), a change of +78.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1401040, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerIncludingAssessedTax; 4 periods shown, dashes mark figures DiaMedica Therapeutics Inc. did not tag for that period.

DiaMedica Therapeutics Inc. has 427 filings in its recent EDGAR index, including 8 annual reports and 23 quarterly reports; its newest filing is a 4 from 2026-08-12.

Current reports. Of the 80 8-K or 6-K reports in DiaMedica Therapeutics Inc.’s recent EDGAR index, the 4 listed here run from 2026-03-31 to 2026-08-10, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1401040 is on the EDGAR company page; the latest 10-K there is dated 2026-03-30 and the oldest filing in the recent index dates from 2007-05-16. Insider trades for DiaMedica Therapeutics Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Digimarc corp

For “Digimarc corp”, the matching SEC registrant is Digimarc Corp, which trades as DMRC and files under Central Index Key 2119322. EDGAR puts it in the “Services-Computer Integrated Systems Design” industry code with OR as its state or country of incorporation; its earlier registered name was Digimarc Parent, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-01, across 47 filings on record. This is reference material, not trading advice.

Financial trend for Digimarc Corp from quarterly and annual reports (three-month periods), periods 2025-06-30 to 2026-06-30: revenue went from $8.01 million (2025-06-30) to $7.39 million (2026-06-30), a change of -7.8%; net income (loss) went from -$8.22 million (2025-06-30) to -$12.11 million (2026-06-30), a change of -47.4%; total assets was tagged only for 2026-06-30 at $45.84 million. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2119322, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 2 periods shown, dashes mark figures Digimarc Corp did not tag for that period.

Digimarc Corp has 47 filings in its recent EDGAR index, including 0 annual reports and 1 quarterly reports; its newest filing is a 4 from 2026-10-01.

Current reports. Of the 6 8-K or 6-K reports in Digimarc Corp’s recent EDGAR index, the 4 listed here run from 2026-07-06 to 2026-09-30, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 47 recent EDGAR filings, Digimarc Corp most often filed 4 (22), 8-K (6), SCHEDULE 13D/A (3), 3 (3). A selection from 2026-09-30 to 2026-10-01:

The full record for CIK 2119322 is on the EDGAR company page and the oldest filing in the recent index dates from 2026-03-12. Insider trades for Digimarc Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Emsign ecc root ca

What this search refers to. “emSign ECC Root CA” is a public certificate authority root operated by eMudhra, an Indian digital-trust company listed on the NSE and BSE; root certificates are published in browser trust stores such as Mozilla’s CCADB. Official source: www.ccadb.org.

No SEC filer could be matched to “Emsign ecc root ca” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Emsign ecc root ca”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “emsign” (search terms considered: emsign, ecc, root).

Even the shorter phrase “Emsign ecc root” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (emsign, ecc, root) point to a business outside the SEC system or one known by another legal name.

EDGAR’s company index has 0 entities whose registered name contains the word “emsign”, so the business is most likely not registered with the SEC under that name.

Word by word, the number of EDGAR registrant names containing each term of this search is: “emsign” 0, “ecc” 19, “root” 71. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “ecc”: ECC ASSOCIATES, LLC (CIK 1642252), ECC BLDG 1, LLC (CIK 1782183), ECC BLDG 2, LLC (CIK 1782242); containing “root”: ANGELICA ROOT LLC (CIK 1619959), COOPER JOHN ABBOTT ROOT (CIK 1756383), D.B. ROOT & COMPANY, LLC (CIK 1731717). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: if “emsign” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Encore capital group ecpg news october 2026

For “Encore capital group ecpg news october 2026”, the matching SEC registrant is ENCORE CAPITAL GROUP INC, which trades as ECPG and files under Central Index Key 1084961. EDGAR puts it in the “Short-Term Business Credit Institutions” industry code with DE as its state or country of incorporation; its earlier registered name was MCM CAPITAL GROUP INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13G filed 2026-10-08, across 1000 filings on record. This is reference material, not trading advice.

Through Cabot Credit Management Limited and its subsidiaries and European affiliates (collectively, “Cabot”) we are one of the largest credit management services providers in Europe and the United Kingdom. These are our primary operations. We also have additional international investments and operations as we have explored new asset classes and geographies including: (1) our subsidiary Encore Asset Reconstruction Company (“EARC”) in India and (2) an investment in portfolio in Mexico. We refer to these additional international operations as our Latin America and Asia-Pacific (“LAAP”) operations. To date, operating results from LAAP have not been significant to our total consolidated operating results. Our long-term growth strategy is focused on continuing to invest in our core portfolio purchasing and recovery business in the United States and United Kingdom and strengthening and developing our business in France and Spain.

Updated Oct 25, 2026 ET

Everus construction group ecg news

For “Everus construction group ecg news”, the matching SEC registrant is Everus Construction Group, Inc., which trades as ECG and files under Central Index Key 2015845. EDGAR puts it in the “Operative Builders” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-09-08, across 144 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-25 by Everus Construction Group, Inc. (CIK 2015845) — source document:

References in this 2025 Annual Report to the “Company”,“Everus”, “we”, “us” or “our” refer to Everus Construction Group, Inc., a Delaware corporation, and its subsidiaries. References in this 2025 Annual Report to “MDU Resources” refer to MDU Resources Group, Inc., a Delaware corporation, and its subsidiaries (other than, after the Distribution, Everus and its subsidiaries), unless the context otherwise requires. References to Everus’ historical business and operations refer to the business and operations of Everus Construction, Inc. (formerly known as MDU Construction Services Group, Inc.) (“Everus Construction”) prior to the Separation and refer to Everus after the Separation. The Separation On November 2, 2023, MDU Resources announced its intent to pursue a tax-free spinoff of Everus Construction (formerly known as MDU Construction Services Group, Inc.) from MDU Resources (the “Separation”).

Financial trend for Everus Construction Group, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $2.70 billion (2022-12-31) to $3.75 billion (2025-12-31), a change of +38.8%; net income (loss) went from $124.78 million (2022-12-31) to $201.77 million (2025-12-31), a change of +61.7%; total assets went from $1.05 billion (2023-12-31) to $1.73 billion (2025-12-31), a change of +64.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2015845, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Everus Construction Group, Inc. did not tag for that period.

For the latest news, the fastest official source is the filing feed: Everus Construction Group, Inc. (CIK 2015845) filed 22 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-09-08, and its overall latest filing is a 8-K dated 2026-09-08. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 22 8-K or 6-K reports in Everus Construction Group, Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-31 to 2026-09-08, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2015845 is on the EDGAR company page; the latest 10-K there is dated 2026-02-25 and the oldest filing in the recent index dates from 2024-03-22. Insider trades for Everus Construction Group, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Fate therapeutics reddit

For “Fate therapeutics reddit”, the matching SEC registrant is FATE THERAPEUTICS INC, which trades as FATE and files under Central Index Key 1434316. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-09-28, across 848 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-26 by FATE THERAPEUTICS INC (CIK 1434316) — source document:

We are a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of off-the-shelf cellular immunotherapies to patients. We have pioneered a therapeutic approach that we generally refer to as cellular programming: we create and engineer human induced pluripotent stem cells (iPSCs) to incorporate novel synthetic controls of cell function; after the engineering step that incorporates multiple functional elements into the iPSCs, we generate a clonal master iPSC line for use as a renewable source of starting material for the manufacture of cell therapies; through the manufacturing process, we direct the fate of the clonal master iPSC line to produce our cell therapy product candidates that are uniform in composition.

Financial trend for FATE THERAPEUTICS INC from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $96.30 million (2022-12-31) to $6.65 million (2025-12-31), a change of -93.1%; net income (loss) went from -$281.72 million (2022-12-31) to -$136.31 million (2025-12-31), a change of +51.6%; total assets went from $705.56 million (2022-12-31) to $318.94 million (2025-12-31), a change of -54.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1434316, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures FATE THERAPEUTICS INC did not tag for that period.

Reddit threads about FATE THERAPEUTICS INC, CIK 1434316, are user opinions, not disclosures. Claims made there can be checked against the filer record: 848 filings sit in its recent EDGAR index, the newest a 8-K dated 2026-09-28, and 357 insider Form 4 reports are among them. The SEC’s Investor.gov site warns that social-media hype around small listed companies is a common feature of pump-and-dump schemes.

Current reports. Of the 132 8-K or 6-K reports in FATE THERAPEUTICS INC’s recent EDGAR index, the 4 listed here run from 2026-06-04 to 2026-09-28, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1434316 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2008-05-02. Insider trades for FATE THERAPEUTICS INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Fatn stock

For “Fatn stock”, the matching SEC registrant is Fatpipe Inc/UT, which trades as FATN and files under Central Index Key 1993400. EDGAR puts it in the “Services-Prepackaged Software” industry code with UT as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-07, across 71 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-05-18 by Fatpipe Inc/UT (CIK 1993400) — source document:

FatPipe is a leading developer of enterprise-class, application-aware, secure SD-WAN solutions and integrated single-stack cybersecurity solutions for organizations, including enterprises, communication service providers, security service providers, government organizations, and other middle-market companies. We strive to be the global leader in delivering leading-edge enterprise-class networking software technology. We are dedicated to continually improving the way organizations connect, ensuring their networks are secure, reliable, and supporting their continued success. Our commitment lies in empowering our customers with a seamless and dependable connectivity infrastructure that safeguards their critical data and fosters business continuity. We further aim to ensure our customers have unparalleled insights into their network operations. We focus on enabling organizations to connect, secure, and monitor their networks through a unified software platform.

Financial trend for Fatpipe Inc/UT from annual reports, periods 2024-03-31 to 2026-03-31: revenue went from $17.86 million (2024-03-31) to $19.21 million (2026-03-31), a change of +7.5%; net income (loss) went from $4.37 million (2024-03-31) to $4.97 million (2026-03-31), a change of +13.8%; total assets went from $21.44 million (2024-03-31) to $34.52 million (2026-03-31), a change of +61.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1993400, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Fatpipe Inc/UT did not tag for that period.

Fatpipe Inc/UT has 71 filings in its recent EDGAR index, including 2 annual reports and 4 quarterly reports; its newest filing is a 8-K from 2026-10-07.

Current reports. Of the 11 8-K or 6-K reports in Fatpipe Inc/UT’s recent EDGAR index, the 4 listed here run from 2026-07-23 to 2026-10-07, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1993400 is on the EDGAR company page; the latest 10-K there is dated 2026-05-18 and the oldest filing in the recent index dates from 2023-10-10. Insider trades for Fatpipe Inc/UT appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Fbgl stock latest company news

For “Fbgl stock latest company news”, the matching SEC registrant is FBS Global Ltd, which trades as FBGL and files under Central Index Key 1938534. EDGAR puts it in the “General Bldg Contractors - Residential Bldgs” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-13 (this view begins at filings dated on or before 2026-04-10), across 99 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-30 by FBS Global Ltd (CIK 1938534) (passage 2, continuing from the earlier excerpt) — source document:

Our Company was incorporated in the Cayman Islands on March 10, 2022 under the Companies Act as an exempted company with limited liability. Our authorized share capital is US$500,000 divided into 500,000,000 shares of par value US$0.001 each. On August 2, 2022, under a group reorganization, our Company became the holding company of our group of companies comprised of Success Elite Developments Limited, a wholly-owned subsidiary, which in turn holds FBS SG, which is our operating company based out of Singapore, FBS Holdings and Bright Bless Developments Limited, a wholly-owned subsidiary. As of the date hereof, Kelvin Ang holds approximately 51.2% of the issued share capital of our Company. Our current corporate structure is as follows: On February 7, 2025, we completed our initial public offering of 2,250,000 Ordinary Shares at a public offering price of US$4.50 per share.

For the latest news, the fastest official source is the filing feed: FBS Global Ltd (CIK 1938534) filed 14 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-13, and its overall latest filing is a 6-K dated 2026-10-13. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 14 8-K or 6-K reports in FBS Global Ltd’s recent EDGAR index, the 4 listed here run from 2026-03-02 to 2026-09-01, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1938534 is on the EDGAR company page; the latest 20-F there is dated 2026-04-30 and the oldest filing in the recent index dates from 2022-09-13. One example from this record is the 6-K filed 2026-09-01 (document). Insider trades for FBS Global Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Frtt stock news

For “Frtt stock news”, the matching SEC registrant is Fort Technology Inc, which trades as FRTT and files under Central Index Key 2092967. EDGAR puts it in the “Agricultural Chemicals” industry code with British Columbia, Canada as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-20, across 20 filings on record. This is reference material, not trading advice.

For the latest news, the fastest official source is the filing feed: Fort Technology Inc (CIK 2092967) filed 9 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-20, and its overall latest filing is a 6-K dated 2026-10-20. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 9 8-K or 6-K reports in Fort Technology Inc’s recent EDGAR index, the 4 listed here run from 2026-08-28 to 2026-10-20, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 20 recent EDGAR filings, Fort Technology Inc most often filed 6-K (9), 20FR12B/A (2), DRS/A (2), S-8 (1). A selection from 2026-06-04 to 2026-10-19:

The full record for CIK 2092967 is on the EDGAR company page and the oldest filing in the recent index dates from 2025-10-22. Insider trades for Fort Technology Inc appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Fs kkr capital fsk latest news october 2026

For “Fs kkr capital fsk latest news october 2026”, the matching SEC registrant is FS KKR Capital Corp, which trades as FSK and files under Central Index Key 1422183. EDGAR puts it in the “no SIC description” industry code with MD as its state or country of incorporation; its earlier registered name was FS Investment CORP. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-08, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-25 by FS KKR Capital Corp (CIK 1422183) — source document:

We are an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company, or BDC, under the Investment Company Act of 1940, as amended, or the 1940 Act. As such, we are required to comply with certain regulatory requirements. In addition, we have elected to be treated for U.S. federal income tax purposes, and intend to qualify annually, as a regulated investment company, or RIC, under Subchapter M of the Internal Revenue Code of 1986, as amended, or the Code. As of December 31, 2025, we had total assets of approximately $13.7 billion. We are managed by FS/KKR Advisor, LLC, or the Adviser, a registered investment adviser under the Investment Advisers Act of 1940, as amended, or the Advisers Act, which oversees the management of our operations and is responsible for making investment decisions with respect to our portfolio.

Financial trend for FS KKR Capital Corp from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from $92.00 million (2022-12-31) to $11.00 million (2025-12-31), a change of -88.0%; total assets went from $16.12 billion (2022-12-31) to $13.73 billion (2025-12-31), a change of -14.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1422183, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures FS KKR Capital Corp did not tag for that period.

For the latest news, the fastest official source is the filing feed: FS KKR Capital Corp (CIK 1422183) filed 300 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-08, and its overall latest filing is a 8-K dated 2026-10-08. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 300 8-K or 6-K reports in FS KKR Capital Corp’s recent EDGAR index, the 4 listed here run from 2026-08-06 to 2026-10-08, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1422183 is on the EDGAR company page; the latest 10-K there is dated 2026-02-25 and the oldest filing in the recent index dates from 2014-02-28. Insider trades for FS KKR Capital Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Gauzy safety tech

For “Gauzy safety tech”, the matching SEC registrant is Gauzy Ltd., which trades as GAUZ and files under Central Index Key 1781446. EDGAR puts it in the “Miscellaneous Electrical Machinery, Equipment & Supplies” industry code with Israel as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-16, across 76 filings on record. This is reference material, not trading advice.

THE OFFER AND LISTING 112 A. Offer and Listing Details 112 B. Plan of Distribution 112 C. Markets 112 D. Selling Shareholders 112 E. Dilution 112 F. Expenses of the Issue 112 i ITEM 10. ADDITIONAL INFORMATION 112 A. Share Capital 112 B. Articles of Association 112 C. Material Contracts 112 D. Exchange Controls 113 E. Taxation 113 F. Dividends and Paying Agents 121 G. Statement by Experts 122 H. Documents on Display 122 I. Subsidiary Information 122 J. Annual Report to Security Holders 122 ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 122 ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 123 PART II 124 ITEM 13.

Gauzy Ltd. has 76 filings in its recent EDGAR index, including 1 annual reports and 0 quarterly reports; its newest filing is a 6-K from 2026-10-16.

Updated Oct 25, 2026 ET

Geo ihd not connecting to smart meter

What this search refers to. “Geo IHD not connecting to smart meter” is a consumer energy support question about a Geo in-home display paired with a UK smart meter; the energy supplier and Smart DCC handle such faults, and there is no securities filing involved. Official source: www.ofgem.gov.uk.

No SEC filer could be matched to “Geo ihd not connecting to smart meter” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Geo ihd not connecting to smart”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “geo” (search terms considered: geo, ihd, not, connecting, smart, meter).

Even the shorter phrase “Geo ihd not” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (geo, ihd, not, connecting, smart, meter) point to a business outside the SEC system or one known by another legal name.

EDGAR’s company index has 99 entities whose registered name contains the word “geo”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “geo” 99, “ihd” 0, “not” 99, “connecting” 3, “smart” 491, “meter” 21. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: if “geo” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Geophysical applications processing srl

What this search refers to. “Geophysical Applications Processing SRL” uses SRL, the Italian or Romanian limited-liability company form; such companies are recorded in the Italian Registro delle Imprese or the Romanian ONRC. Corporate-registry check: OpenCorporates search for “Geophysical applications processing srl”.

No SEC filer could be matched to “Geophysical applications processing srl” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Geophysical applications processing srl”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “geophysical” (search terms considered: geophysical, applications, processing, srl).

Even the shorter phrase “Geophysical applications processing” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (geophysical, applications, processing, srl) point to a business outside the SEC system or one known by another legal name.

EDGAR’s company index has 37 entities whose registered name contains the word “geophysical”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “geophysical” 37, “applications” 77, “processing” 163, “srl” 25. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “geophysical”: 3-D GEOPHYSICAL INC (CIK 1003382), DAWSON GEOPHYSICAL CO (CIK 351231), DAWSON GEOPHYSICAL CO (CIK 799165); containing “applications”: A.D. INTEGRITY APPLICATIONS LTD. (CIK 1487546), ACORN APPLICATIONS LLC (CIK 1642705), ADJACENT APPLICATIONS, INC. (CIK 1534572); containing “processing”: 1ST NATIONAL PROCESSING, INC (CIK 1364667), ABBY'S ANGELS PROCESSING, INC. (CIK 1792962), ACCESS WEST TEXAS PROCESSING, L.L.C. (CIK 1601564); containing “srl”: A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE SRL (CIK 1810515), ASTRANTUS INVESTMENT MANAGEMENT SRL (CIK 1955207), BOOMERANGFX INTERNATIONAL SRL (CIK 1812423). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: if “geophysical” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Goodrx careers ai machine learning engineer jobs

For “Goodrx careers ai machine learning engineer jobs”, the matching SEC registrant is GoodRx Holdings, Inc., which trades as GDRX and files under Central Index Key 1809519. EDGAR puts it in the “Services-Computer Processing & Data Preparation” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-15, across 580 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-26 by GoodRx Holdings, Inc. (CIK 1809519) — source document:

Our mission is to help Americans save time and money when filling their medications. To achieve this, we are building the leading, consumer-focused digital healthcare platform in the United States. GoodRx was founded to solve the challenges that consumers face in understanding, accessing, and affording healthcare by removing the friction and inefficiencies in the system. We started with a price comparison tool for prescriptions, offering consumers free access to lower prices on their medication. This price comparison platform processes over 420 billion pricing data points every day and integrates that data into a user-friendly interface which provides consumers with dynamic, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that can be used to save money on prescriptions across the United States.

Financial trend for GoodRx Holdings, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $766.55 million (2022-12-31) to $796.85 million (2025-12-31), a change of +4.0%; net income (loss) went from -$32.83 million (2022-12-31) to $30.44 million (2025-12-31), a change of +192.7%; total assets went from $1.60 billion (2022-12-31) to $1.40 billion (2025-12-31), a change of -12.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1809519, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures GoodRx Holdings, Inc. did not tag for that period.

For reported results, GoodRx Holdings, Inc.’s (CIK 1809519) latest 10-Q is dated 2026-08-05 and its latest annual report (10-K) 2026-02-26. Earnings releases appear as 8-K Item 2.02 filings; 26 are in the recent index, the newest on 2026-08-05.

Current reports. Of the 75 8-K or 6-K reports in GoodRx Holdings, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-06 to 2026-08-05, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1809519 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2020-04-16. Insider trades for GoodRx Holdings, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Greenwich lifesciences glsi-100 latest news october 2026

For “Greenwich lifesciences glsi-100 latest news october 2026”, the matching SEC registrant is Greenwich LifeSciences, Inc., which trades as GLSI and files under Central Index Key 1799788. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 10-Q filed 2026-08-11 (this view begins at filings dated on or before 2025-11-03), across 276 filings on record. This is reference material, not trading advice.

More of the filing record for Greenwich LifeSciences, Inc. (CIK 1799788), filings 2025-11-03 to 2025-11-12: 4 on 2025-11-12; 4 on 2025-11-04; ARS on 2025-11-03; DEFA14A on 2025-11-03; DEF 14A on 2025-11-03. Each form type has a fixed purpose under SEC rules, so the mix shows what kind of events the company has been reporting.

Updated Oct 25, 2026 ET

Greenwich lifesciences press releases glsi-100

For “Greenwich lifesciences press releases glsi-100”, the matching SEC registrant is Greenwich LifeSciences, Inc., which trades as GLSI and files under Central Index Key 1799788. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 10-Q filed 2026-08-11 (this view begins at filings dated on or before 2025-03-31), across 276 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-06-01 by Greenwich LifeSciences, Inc. (CIK 1799788) (passage 4, continuing from the earlier excerpt) — source document:

Financial trend for Greenwich LifeSciences, Inc. from quarterly and annual reports (three-month periods), periods 2024-09-30 to 2025-06-30: net income (loss) went from -$2.67 million (2024-09-30) to -$3.75 million (2025-06-30), a change of -40.5%; total assets went from $5.83 million (2024-09-30) to $3.13 million (2025-06-30), a change of -46.4%. Values are as filed and not adjusted for restatements, splits or currency.

Current reports. Of the 31 8-K or 6-K reports in Greenwich LifeSciences, Inc.’s recent EDGAR index, the 4 listed here run from 2021-11-10 to 2022-07-11, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1799788 is on the EDGAR company page; the latest 10-K there is dated 2026-06-01 and the oldest filing in the recent index dates from 2020-01-27. One example from this record is the 4 filed 2026-01-02 (document). Insider trades for Greenwich LifeSciences, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Gulfport energy gpor latest news

For “Gulfport energy gpor latest news”, the matching SEC registrant is GULFPORT ENERGY CORP, which trades as GPOR and files under Central Index Key 874499. EDGAR puts it in the “Crude Petroleum & Natural Gas” industry code with an unstated jurisdiction as its state or country of incorporation; its earlier registered name was WRT ENERGY CORP. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-09-25, across 1000 filings on record. This is reference material, not trading advice.

See “Definitions” above for our definition of PV-10 (a non-GAAP financial measure) and “Oil, Natural Gas and NGL Reserves and Estimation” below for a reconciliation of our standardized measure of discounted future net cash flows (the most directly comparable GAAP measure) to PV-10. Information About Us Our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and all amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act are made available free of charge on the Investor Relations page of our website at www.gulfportenergy.com as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. From time to time, we also post announcements, updates, events, investor information and presentations on our website in addition to copies of our recent news releases.

Updated Oct 25, 2026 ET

Gva real estate group funding leadership acquisition partnership expansion

What this search refers to. “GVA real estate group” refers to a real-estate business; the query mixes funding, leadership and acquisition terms, but no SEC registrant uses that name, so news would come from the firm itself. Corporate-registry check: OpenCorporates search for “Gva real estate group funding leadership acquisition partnership expansion”.

No SEC filer could be matched to “Gva real estate group funding leadership acquisition partnership expansion” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Gva real estate group funding leadership”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “gva” (search terms considered: gva, real, estate, funding, leadership, acquisition, partnership, expansion).

A broader EDGAR full-text search for the shorter phrase “Gva real estate” finds 13 filing documents; among the top 13, the filers mentioning it most are COSTAR GROUP INC (CSGP) (CIK 0001057352) (9); HAWTHORNE FINANCIAL CORP (CIK 0000046267) (3); YieldStreet Prism Fund Inc. (CIK 0001762229) (1). Those are documents that name the term, not proof that any of these filers is the business in the search.

EDGAR’s company index has 59 entities whose registered name contains the word “gva”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “gva” 59, “real” 477, “estate” 475, “funding” 494, “leadership” 30, “acquisition” 480. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: a SPAC, IPO or merger involving “gva” would leave an S-1, F-1, S-4 or 425 filing on EDGAR once it is public, and its absence means no U.S. registered offering has been filed under that name. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Helport ai hpai press release october 2026

For “Helport ai hpai press release october 2026”, the matching SEC registrant is Helport AI Ltd, which trades as HPAI, HPAIW and files under Central Index Key 2001699. EDGAR puts it in the “Services-Prepackaged Software” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-07-10 (this view begins at filings dated on or before 2024-07-05), across 62 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2025-11-17 by Helport AI Ltd (CIK 2001699) (passage 5, continuing from the earlier excerpt) — source document:

Other filings. Across its 62 recent EDGAR filings, Helport AI Ltd most often filed 6-K (11), CORRESP (9), UPLOAD (8), 3 (6). A selection from 2024-08-02 to 2024-12-04:

Updated Oct 25, 2026 ET

Helport ai latest news

For “Helport ai latest news”, the matching SEC registrant is Helport AI Ltd, which trades as HPAI, HPAIW and files under Central Index Key 2001699. EDGAR puts it in the “Services-Prepackaged Software” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-07-10 (this view begins at filings dated on or before 2024-06-04), across 62 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2025-11-17 by Helport AI Ltd (CIK 2001699) (passage 6, continuing from the earlier excerpt) — source document:

The “Knowledge Base Assistant” function enables rapid construction of knowledge bases (utilizing large language models) and the continuous upgrading of such knowledge bases, which is one of our key capabilities for AI training and labeling. With these functions, we believe that AI Assist is an all-in-one tool that helps companies enhance customer engagement efficiency and can assist them in their efforts to achieve exceptional sales performance. 28 For clients in need of customer engagement professionals, we offer our AI+BPO service, which combines AI software with customer contact agents. With this offering, we provide customer contact agents who utilize our AI Assist software to perform their tasks. In this way, we help clients enjoy flexible, outsourced professional services while showcasing the efficacy of our AI software.

Other filings. Across its 62 recent EDGAR filings, Helport AI Ltd most often filed 6-K (11), CORRESP (9), UPLOAD (8), 3 (6). A selection from 2024-07-05 to 2024-08-02:

The full record for CIK 2001699 is on the EDGAR company page; the latest 20-F there is dated 2025-11-17 and the oldest filing in the recent index dates from 2023-12-22. One example from this record is the 6-K filed 2025-10-24 (document). Insider trades for Helport AI Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Imsr

For “Imsr”, the matching SEC registrant is Terrestrial Energy Inc. /DE/, which trades as IMSR, IMSRW and files under Central Index Key 2019804. EDGAR puts it in the “Fabricated Plate Work (Boiler Shops)” industry code with DE as its state or country of incorporation; its earlier registered name was HCM II Acquisition Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-21, across 180 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-30 by Terrestrial Energy Inc. /DE/ (CIK 2019804) — source document:

References in this section to “we,” “our,” “us,” the “Company” or “Terrestrial Energy” generally refer to Terrestrial Energy Inc. and its subsidiaries. Mission Terrestrial Energy Inc. is an advanced nuclear technology company developing the Integral Molten Salt Reactor nuclear plant (“IMSR Plant”), which uses the Company’s proprietary design of Molten Salt Reactor (“MSR”). Our mission is to transform global energy markets by commercializing our IMSR Plant, which will deliver low-carbon electricity and industrial heat with superior economics, speed to deployment, and siting flexibility. In a world demanding rapid, scalable nuclear solutions, the IMSR Plant offers a viable, efficient alternative to both the limitations of legacy nuclear and the intermittency of renewables.

Financial trend for Terrestrial Energy Inc. /DE/ from annual reports, periods 2024-12-31 to 2025-12-31: revenue was tagged only for 2024-12-31 at $248,357; net income (loss) went from -$11.49 million (2024-12-31) to -$28.02 million (2025-12-31), a change of -143.9%; total assets went from $5.33 million (2024-12-31) to $302.98 million (2025-12-31), a change of +5582.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2019804, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 2 periods shown, dashes mark figures Terrestrial Energy Inc. /DE/ did not tag for that period.

Terrestrial Energy Inc. /DE/ has 180 filings in its recent EDGAR index, including 2 annual reports and 7 quarterly reports; its newest filing is a 4 from 2026-10-21.

Current reports. Of the 21 8-K or 6-K reports in Terrestrial Energy Inc. /DE/’s recent EDGAR index, the 4 listed here run from 2026-07-21 to 2026-08-11, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2019804 is on the EDGAR company page; the latest 10-K there is dated 2026-03-30 and the oldest filing in the recent index dates from 2024-04-26. Insider trades for Terrestrial Energy Inc. /DE/ appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Inflarx

For “Inflarx”, the matching SEC registrant is InflaRx N.V., which trades as IFRX and files under Central Index Key 1708688. EDGAR puts it in the “Pharmaceutical Preparations” industry code with Netherlands as its state or country of incorporation; its earlier registered name was Fireman B.V.. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-22, across 287 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-03-20 by InflaRx N.V. (CIK 1708688) — source document:

OPERATING AND FINANCIAL REVIEW AND PROSPECTS 86 A. Operating results 86 B. Financial operations overview 87 C. Liquidity and capital resources 92 D. Research and development, patents and licenses, etc. 95 E. Trend information 95 F. Critical accounting estimates 95 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 96 A. Directors and senior management 96 B. Compensation 99 C. Board practices 102 D. Employees 104 E. Share ownership 104 - i - F. Disclosure of a registrant’s action to recover erroneously awarded compensation 105 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 106 A. Major shareholders 106 B. Related party transactions 109 ITEM 8. FINANCIAL INFORMATION 110 A. Consolidated statements and other financial information 110 B. Significant changes 110 ITEM 9.

Financial trend for InflaRx N.V. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from 63,089 EUR (2023-12-31) to 29,331 EUR (2025-12-31), a change of -53.5%; net income (loss) went from -29,484,611 EUR (2022-12-31) to -45,633,780 EUR (2025-12-31), a change of -54.8%; total assets went from 102,399,660 EUR (2022-12-31) to 55,216,297 EUR (2025-12-31), a change of -46.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1708688, tags Assets, ProfitLoss, Revenue; 4 periods shown, dashes mark figures InflaRx N.V. did not tag for that period.

InflaRx N.V. has 287 filings in its recent EDGAR index, including 9 annual reports and 0 quarterly reports; its newest filing is a 6-K from 2026-10-22.

Current reports. Of the 152 8-K or 6-K reports in InflaRx N.V.’s recent EDGAR index, the 4 listed here run from 2026-05-07 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1708688 is on the EDGAR company page; the latest 20-F there is dated 2026-03-20 and the oldest filing in the recent index dates from 2017-06-23. Insider trades for InflaRx N.V. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Ingn stock reddit

For “Ingn stock reddit”, the matching SEC registrant is Inogen Inc, which trades as INGN and files under Central Index Key 1294133. EDGAR puts it in the “Orthopedic, Prosthetic & Surgical Appliances & Supplies” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-09-30, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-27 by Inogen Inc (CIK 1294133) — source document:

Inogen, Inc. is a medical technology business that primarily focuses on respiratory health. We develop, manufacture, and market innovative respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox ® product for airway clearance treatment. In addition, we have started distributing the Inogen Voxi ® 5 stationary oxygen concentrator as well as the Aurora ® continuous positive airway pressure, or CPAP, masks in the United States. Our proprietary Inogen One ® and Inogen Rove ® POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.

Financial trend for Inogen Inc from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $377.24 million (2022-12-31) to $348.67 million (2025-12-31), a change of -7.6%; net income (loss) went from -$83.77 million (2022-12-31) to -$22.75 million (2025-12-31), a change of +72.8%; total assets went from $405.04 million (2022-12-31) to $298.62 million (2025-12-31), a change of -26.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1294133, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Inogen Inc did not tag for that period.

Reddit threads about Inogen Inc, CIK 1294133, are user opinions, not disclosures. Claims made there can be checked against the filer record: 1000 filings sit in its recent EDGAR index, the newest a 8-K dated 2026-09-30, and 574 insider Form 4 reports are among them. The SEC’s Investor.gov site warns that social-media hype around small listed companies is a common feature of pump-and-dump schemes.

Current reports. Of the 139 8-K or 6-K reports in Inogen Inc’s recent EDGAR index, the 4 listed here run from 2026-06-11 to 2026-09-30, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1294133 is on the EDGAR company page; the latest 10-K there is dated 2026-02-27 and the oldest filing in the recent index dates from 2006-09-22. Insider trades for Inogen Inc appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Intermediate dutch holdco nl

“N.V.” and “B.V.” are Dutch public and private limited company forms. The name “Intermediate dutch holdco nl” therefore points to a company organised in the Netherlands, and its official disclosures are on the Dutch AFM registers and the KvK commercial register (www.afm.nl), not on EDGAR.

No SEC filer could be matched to “Intermediate dutch holdco nl” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Intermediate dutch holdco nl”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “intermediate” (search terms considered: intermediate, dutch, holdco).

A broader EDGAR full-text search for the shorter phrase “Intermediate dutch holdco” finds 4 filing documents; among the top 4, the filers mentioning it most are Metinvest B.V. (CIK 0001638371) (2); CNH GLOBAL N V (CIK 0001024519) (1); FI CBM Holdings N.V. (CNH) (CIK 0001567094) (1). Those are documents that name the term, not proof that any of these filers is the business in the search.

EDGAR’s company index has 176+ entities whose registered name contains the word “intermediate”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “intermediate” 444, “dutch” 44, “holdco” 493. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: if “intermediate” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Investors.ao-inc.com applied optoelectronics october 2026 press release

For “Investors.ao-inc.com applied optoelectronics october 2026 press release”, the matching SEC registrant is APPLIED OPTOELECTRONICS, INC., which trades as AAOI and files under Central Index Key 1158114. EDGAR puts it in the “Semiconductors & Related Devices” industry code with DE as its state or country of incorporation; its earlier registered name was APPLIED OPTOELECTRONICS INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-14, across 1004 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-26 by APPLIED OPTOELECTRONICS, INC. (CIK 1158114) — source document:

Applied Optoelectronics, Inc. (the "Company" or "AOI") is a leading, vertically integrated provider of fiber-optic networking products, primarily for four networking end-markets: internet data center, cable television ("CATV"), telecommunications, ("telecom"), and fiber-to-the-home ("FTTH"). We design and manufacture a range of optical communications products at varying levels of integration, from components, subassemblies and modules to complete turn-key equipment. In designing products for our customers, we typically begin with the fundamental building blocks of lasers and laser components. From these foundational products, we design and manufacture a wide range of products to meet our customers’ needs and specifications, and such products differ from each other by their end market, intended use and level of integration.

Financial trend for APPLIED OPTOELECTRONICS, INC. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $222.82 million (2022-12-31) to $455.71 million (2025-12-31), a change of +104.5%; net income (loss) went from -$66.40 million (2022-12-31) to -$38.23 million (2025-12-31), a change of +42.4%; total assets went from $408.26 million (2022-12-31) to $1.17 billion (2025-12-31), a change of +186.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1158114, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures APPLIED OPTOELECTRONICS, INC. did not tag for that period.

For the latest news, the fastest official source is the filing feed: APPLIED OPTOELECTRONICS, INC. (CIK 1158114) filed 141 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-09-15, and its overall latest filing is a 4 dated 2026-10-14. Companies must file an 8-K within four business days of most material events.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for APPLIED OPTOELECTRONICS, INC. (CIK 1158114) lists its business address as 13139 JESS PIRTLE BLVD, SUGAR LAND, TX, which helps confirm you are on the right company’s site.

Current reports. Of the 141 8-K or 6-K reports in APPLIED OPTOELECTRONICS, INC.’s recent EDGAR index, the 4 listed here run from 2026-08-24 to 2026-09-15, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1158114 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2017-11-08. Insider trades for APPLIED OPTOELECTRONICS, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Ixhl stock reddit

For “Ixhl stock reddit”, the matching SEC registrant is Incannex Healthcare Inc., which trades as IXHL and files under Central Index Key 1873875. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was Incannex Healthcare Ltd. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 10-K filed 2026-09-25 (this view begins at filings dated on or before 2026-05-14), across 263 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-09-25 by Incannex Healthcare Inc. (CIK 1873875) (passage 2, continuing from the earlier excerpt) — source document:

In December 2025, the U.S. Food and Drug Administration (“FDA”) granted Fast Track designation for IHL-42X for the treatment of OSA. We have determined to conduct an additional dose confirmation study, the DReAMzz Study, to further optimize the ratio of dronabinol and acetazolamide prior to advancing into a Phase 3 clinical trial of IHL-42X. The DReAMzz Study is a Phase 2 dose confirmation crossover trial evaluating nine dose combinations of IHL-42X across approximately 120 subjects at 14 U.S. clinical sites. This study commenced in May 2026, began screening participants in July 2026, is currently enrolling participants, and is estimated to be completed in mid-2027. Results from the DReAMzz Study are expected to inform the design of a planned Phase 3 clinical trial for IHL-42X. PSX-001, our other lead drug candidate in clinical development following completion of a Phase 2 trial, is an oral synthetic psilocybin treatment, administered in combination with psychological therapy for patients with moderate-to-severe generalized anxiety disorder (“GAD”).

Financial trend for Incannex Healthcare Inc. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-03-31: net income (loss) went from -$6.41 million (2025-09-30) to -$3.88 million (2026-03-31), a change of +39.4%; total assets went from $78.72 million (2025-09-30) to $80.28 million (2026-03-31), a change of +2.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1873875, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Incannex Healthcare Inc. did not tag for that period.

Reddit threads about Incannex Healthcare Inc., CIK 1873875, are user opinions, not disclosures. Claims made there can be checked against the filer record: 263 filings sit in its recent EDGAR index, the newest a 10-K dated 2026-09-25, and 12 insider Form 4 reports are among them. The SEC’s Investor.gov site warns that social-media hype around small listed companies is a common feature of pump-and-dump schemes.

Current reports. Of the 151 8-K or 6-K reports in Incannex Healthcare Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-14 to 2026-06-25, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1873875 is on the EDGAR company page; the latest 10-K there is dated 2026-09-25 and the oldest filing in the recent index dates from 2021-08-17. One example from this record is the 8-K filed 2026-08-11 (document). Insider trades for Incannex Healthcare Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Jyong biotech ltd

For “Jyong biotech ltd”, the matching SEC registrant is Jyong Biotech Ltd., which trades as MENS and files under Central Index Key 1954488. EDGAR puts it in the “Pharmaceutical Preparations” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 20-F filed 2026-05-15, across 73 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-05-15 by Jyong Biotech Ltd. (CIK 1954488) — source document:

Jyong Biotech Ltd. is a Cayman Islands exempted company incorporated on January 26, 2018 and we primarily conduct our operations through our wholly owned subsidiaries in Taiwan. We commenced our commercial operations in July 2002 through Health Ever Bio-Tech Co., Ltd., which has been wholly owned by Jyong Biotech Ltd. since August 2018. In September 2019, we established Genvace Biotechnology Co., Ltd., a Taiwan subsidiary wholly owned by Health Ever Bio-Tech Co., Ltd. for the research and development of health products. Our Hong Kong subsidiary, Top ShunXing Bio-Tech Co., Limited, was established in March 2019, with Jyong Biotech Ltd. as its sole shareholder. Top ShunXing Bio-Tech Co., Limited is a holding company and has no substantial operations in Hong Kong, except that in October 2020, all intellectual properties of Health Ever Bio-Tech Co., Ltd. were transferred to Top ShunXing Bio-Tech Co., Limited for the sake of centralized management and that in August 2019, it borrowed approximately US$ 2.3 million from third parties to invest our PRC subsidiary via capital contribution.

Financial trend for Jyong Biotech Ltd. from annual reports, periods 2023-12-31 to 2025-12-31: net income (loss) went from -$4.40 million (2023-12-31) to -$4.67 million (2025-12-31), a change of -6.2%; total assets went from $6.37 million (2024-12-31) to $20.78 million (2025-12-31), a change of +226.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1954488, tags Assets, NetIncomeLoss; 3 periods shown, dashes mark figures Jyong Biotech Ltd. did not tag for that period.

Jyong Biotech Ltd. has 73 filings in its recent EDGAR index, including 1 annual reports and 0 quarterly reports; its newest filing is a 20-F from 2026-05-15.

Current reports. Of the 3 8-K or 6-K reports in Jyong Biotech Ltd.’s recent EDGAR index, the 3 listed here run from 2025-06-20 to 2026-02-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1954488 is on the EDGAR company page; the latest 20-F there is dated 2026-05-15 and the oldest filing in the recent index dates from 2023-03-16. Insider trades for Jyong Biotech Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Legence lgn

For “Legence lgn”, the matching SEC registrant is Legence Corp., which trades as LGN and files under Central Index Key 2052568. EDGAR puts it in the “Construction - Special Trade Contractors” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-09-22, across 109 filings on record. This is reference material, not trading advice.

Financial trend for Legence Corp. from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from $1.62 billion (2023-12-31) to $2.55 billion (2025-12-31), a change of +57.9%; net income (loss) went from -$46.03 million (2023-12-31) to -$59.78 million (2025-12-31), a change of -29.9%; total assets went from $2.35 billion (2024-12-31) to $2.68 billion (2025-12-31), a change of +13.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2052568, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 3 periods shown, dashes mark figures Legence Corp. did not tag for that period.

Legence Corp. has 109 filings in its recent EDGAR index, including 1 annual reports and 3 quarterly reports; its newest filing is a 4 from 2026-09-22.

Current reports. Of the 12 8-K or 6-K reports in Legence Corp.’s recent EDGAR index, the 4 listed here run from 2026-05-14 to 2026-08-18, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 109 recent EDGAR filings, Legence Corp. most often filed 4 (32), 3 (15), 8-K (12), SCHEDULE 13G/A (6). A selection from 2026-09-17 to 2026-09-22:

The full record for CIK 2052568 is on the EDGAR company page; the latest 10-K there is dated 2026-03-30 and the oldest filing in the recent index dates from 2025-02-14. Insider trades for Legence Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Lgo hospitality acquired

What this search refers to. For “LGO Hospitality acquired”, there is no SEC filing because LGO Hospitality is privately held; an acquisition would be confirmed by the buyer’s or company’s announcement and Arizona Corporation Commission records. Official source: ecorp.azcc.gov.

No SEC filer could be matched to “Lgo hospitality acquired” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Lgo hospitality acquired”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “lgo” (search terms considered: lgo, hospitality, acquired).

Word by word, the number of EDGAR registrant names containing each term of this search is: “lgo” 3, “hospitality” 492, “acquired” 11. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “lgo”: LGO ACCESS II LLC (CIK 1303920), LGO ACCESS LLC (CIK 1195727), LGO ACCESS LTD (CIK 1212836); containing “hospitality”: 509 HOSPITALITY LENDERS, LLC (CIK 1974937), 8ELEVEN HOSPITALITY GROUP, INC (CIK 1923949), AC HOSPITALITY, LLC, A CALIFORNIA LTD LIABILITY CO (CIK 1746410); containing “acquired”: ACQUIRED SALES CORP (CIK 1391135), ACQUIRED WISDOM FUND I, LP (CIK 1882293), CLEARLY ACQUIRED LLC (CIK 2063363). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: if “lgo” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Louisiana-pacific lpx

For “Louisiana-pacific lpx”, the matching SEC registrant is LOUISIANA-PACIFIC CORP, which trades as LPX and files under Central Index Key 60519. EDGAR puts it in the “Lumber & Wood Products (No Furniture)” industry code with DE as its state or country of incorporation; its earlier registered name was LOUISIANA PACIFIC CORP. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-09-03, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-17 by LOUISIANA-PACIFIC CORP (CIK 60519) — source document:

We are a leading provider of high-performance building solutions that meet the demands of builders, remodelers, and homeowners worldwide. Serving the new home construction, repair and remodeling, and outdoor structures markets, we have leveraged our expertise to become an industry leader known for innovation, quality, reliability, and sustainability. The principal customers for our building solutions are retailers, wholesalers, and home building and industrial businesses in North America and South America. Since our founding in 1972, LP has been Building a Better World ™ by helping customers construct beautiful, durable homes while shareholders build lasting value. We are headquartered in Nashville, Tennessee, and as of December 31, 2025, we operate more than 20 manufacturing facilities across North and South America.

Financial trend for LOUISIANA-PACIFIC CORP from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $3.85 billion (2022-12-31) to $2.71 billion (2025-12-31), a change of -29.7%; net income (loss) went from $1.09 billion (2022-12-31) to $146.00 million (2025-12-31), a change of -86.6%; total assets went from $2.35 billion (2022-12-31) to $2.63 billion (2025-12-31), a change of +11.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 60519, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures LOUISIANA-PACIFIC CORP did not tag for that period.

LOUISIANA-PACIFIC CORP has 1000 filings in its recent EDGAR index, including 16 annual reports and 47 quarterly reports; its newest filing is a 4 from 2026-09-03.

Current reports. Of the 169 8-K or 6-K reports in LOUISIANA-PACIFIC CORP’s recent EDGAR index, the 4 listed here run from 2026-06-01 to 2026-09-01, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 60519 is on the EDGAR company page; the latest 10-K there is dated 2026-02-17 and the oldest filing in the recent index dates from 2011-02-02. Insider trades for LOUISIANA-PACIFIC CORP appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET